Suppr超能文献

相似文献

6
Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus.
Neurosci Res. 2011 Mar;69(3):203-13. doi: 10.1016/j.neures.2010.12.002. Epub 2010 Dec 9.
7
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors.
Br J Pharmacol. 2018 Jul;175(14):2911-2925. doi: 10.1111/bph.14329. Epub 2018 Jun 7.
9
Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
Neuroscience. 2006;137(1):113-23. doi: 10.1016/j.neuroscience.2005.08.063. Epub 2005 Oct 20.
10
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Eur J Pharmacol. 2005 Feb 21;509(2-3):97-108. doi: 10.1016/j.ejphar.2004.12.037.

引用本文的文献

1
A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential.
Alzheimers Dement (N Y). 2022 Apr 5;8(1):e12274. doi: 10.1002/trc2.12274. eCollection 2022.
2
Ca Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease.
Cells. 2020 Dec 10;9(12):2655. doi: 10.3390/cells9122655.
3
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine.
J Neurochem. 2021 Sep;158(6):1359-1380. doi: 10.1111/jnc.15243. Epub 2021 Jan 8.
4
Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.
Rev Endocr Metab Disord. 2020 Dec;21(4):431-447. doi: 10.1007/s11154-020-09584-3. Epub 2020 Aug 26.
6
Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma.
Neurobiol Dis. 2020 Feb;134:104695. doi: 10.1016/j.nbd.2019.104695. Epub 2019 Nov 25.
8
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors.
Br J Pharmacol. 2018 Jul;175(14):2911-2925. doi: 10.1111/bph.14329. Epub 2018 Jun 7.
9
Acetylcholine nicotinic receptor subtypes in chromaffin cells.
Pflugers Arch. 2018 Jan;470(1):13-20. doi: 10.1007/s00424-017-2050-7. Epub 2017 Aug 8.

本文引用的文献

1
Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release.
Mol Pharmacol. 2004 Sep;66(3):538-44. doi: 10.1124/mol.104.000299.
3
Clinical experience of galantamine in dementia: a series of case reports.
Curr Med Res Opin. 2003;19(6):508-18. doi: 10.1185/030079903125002054.
4
Cholinergic function and Alzheimer's disease.
Int J Geriatr Psychiatry. 2003 Sep;18(Suppl 1):S1-5. doi: 10.1002/gps.935.
5
Single synaptic vesicles fusing transiently and successively without loss of identity.
Nature. 2003 Jun 5;423(6940):643-7. doi: 10.1038/nature01686.
6
Three modes of synaptic vesicular recycling revealed by single-vesicle imaging.
Nature. 2003 Jun 5;423(6940):607-13. doi: 10.1038/nature01677.
7
The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals.
Br J Pharmacol. 2003 Apr;138(8):1580-8. doi: 10.1038/sj.bjp.0705204.
8
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
J Pharmacol Exp Ther. 2003 Jun;305(3):1024-36. doi: 10.1124/jpet.102.045773. Epub 2003 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验